
Sabiha Naim Qazi
Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5666664
[patent_doc_number] => 20060172014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Treatment of lung cancer with active vitamin D compounds in combination with other treatments'
[patent_app_type] => utility
[patent_app_number] => 11/298927
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19110
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298927 | Treatment of lung cancer with active vitamin D compounds in combination with other treatments | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5672020
[patent_doc_number] => 20060177374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments'
[patent_app_type] => utility
[patent_app_number] => 11/298931
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20107
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177374.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298931 | Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5672996
[patent_doc_number] => 20060178351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/298989
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26153
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298989 | Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5649756
[patent_doc_number] => 20060135491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Vitamin D3 analog useful for the treatment of osteoporosis'
[patent_app_type] => utility
[patent_app_number] => 11/295007
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14845
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295007 | Vitamin D3 analog useful for the treatment of osteoporosis | Dec 5, 2005 | Abandoned |
Array
(
[id] => 4534412
[patent_doc_number] => 07888338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => '7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes'
[patent_app_type] => utility
[patent_app_number] => 11/295000
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42417
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295000
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295000 | 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes | Dec 5, 2005 | Issued |
Array
(
[id] => 4652259
[patent_doc_number] => 20080039515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Arylpyrazoles And Methods Of Using Same For Control Of Insect Pests That Bore Into Trees'
[patent_app_type] => utility
[patent_app_number] => 11/791899
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11079
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039515.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791899 | Arylpyrazoles And Methods Of Using Same For Control Of Insect Pests That Bore Into Trees | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5252830
[patent_doc_number] => 20070134286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals'
[patent_app_type] => utility
[patent_app_number] => 11/292050
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10088
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134286.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292050 | Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5844327
[patent_doc_number] => 20060122117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Method of treating retinopathies and disorders associated with blood vessel loss'
[patent_app_type] => utility
[patent_app_number] => 11/287152
[patent_app_country] => US
[patent_app_date] => 2005-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8066
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122117.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287152
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287152 | Method of treating retinopathies and disorders associated with blood vessel loss | Nov 24, 2005 | Abandoned |
Array
(
[id] => 5721479
[patent_doc_number] => 20060074255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => '3-Methyl-20-epi-vitamin D derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/282643
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3591
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074255.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282643
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282643 | 3-Methyl-20-epi-vitamin D derivatives | Nov 20, 2005 | Abandoned |
Array
(
[id] => 5614424
[patent_doc_number] => 20060116352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => '2alpha-Methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/283124
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10342
[patent_no_of_claims] => 151
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283124 | 2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Nov 17, 2005 | Issued |
Array
(
[id] => 5844401
[patent_doc_number] => 20060122157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => '2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/283222
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7886
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122157.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283222 | 2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses | Nov 17, 2005 | Issued |
Array
(
[id] => 5748389
[patent_doc_number] => 20060111321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => '2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/283125
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7752
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283125 | 2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses | Nov 17, 2005 | Issued |
Array
(
[id] => 5614423
[patent_doc_number] => 20060116351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => '17,20(Z)-dehydro vitamin D analogs and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/283090
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11469
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283090
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283090 | 17,20(Z)-dehydro vitamin D analogs and their uses | Nov 17, 2005 | Issued |
Array
(
[id] => 8294450
[patent_doc_number] => 08222235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => '2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol'
[patent_app_type] => utility
[patent_app_number] => 11/282972
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5841
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11282972
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282972 | 2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol | Nov 17, 2005 | Issued |
Array
(
[id] => 5632289
[patent_doc_number] => 20060148759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => '2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/283261
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6267
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148759.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283261 | 2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses | Nov 17, 2005 | Issued |
Array
(
[id] => 8006183
[patent_doc_number] => 08084492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Benzofuran compound and pharmaceutical composition containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/791026
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7816
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791026 | Benzofuran compound and pharmaceutical composition containing the same | Nov 17, 2005 | Issued |
Array
(
[id] => 5650063
[patent_doc_number] => 20060135798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => '2-Methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol'
[patent_app_type] => utility
[patent_app_number] => 11/282304
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282304
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282304 | 2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol | Nov 17, 2005 | Issued |
Array
(
[id] => 5650065
[patent_doc_number] => 20060135800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => '2-Methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol'
[patent_app_type] => utility
[patent_app_number] => 11/283541
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5711
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135800.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283541 | 2-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferol | Nov 17, 2005 | Issued |
Array
(
[id] => 460041
[patent_doc_number] => 07241752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-10
[patent_title] => '17,20(E)-dehydro vitamin D analogs and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/283291
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11285
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283291 | 17,20(E)-dehydro vitamin D analogs and their uses | Nov 17, 2005 | Issued |
Array
(
[id] => 5596851
[patent_doc_number] => 20060160769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => '2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/283163
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5685
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283163
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283163 | 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses | Nov 17, 2005 | Issued |